Your browser doesn't support javascript.
loading
IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events.
Gu, Stephanie L; Maier, Tara; Moy, Andrea P; Dusza, Stephen; Faleck, David M; Shah, Neil J; Lacouture, Mario E.
Affiliation
  • Gu SL; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
  • Maier T; Department of Dermatology, Weill Cornell Medical College, New York, NY 10021, USA.
  • Moy AP; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
  • Dusza S; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Faleck DM; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
  • Shah NJ; Gastroenterology, Hepatology, and Nutrition Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Lacouture ME; Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA.
Pharmaceuticals (Basel) ; 16(11)2023 Nov 02.
Article in En | MEDLINE | ID: mdl-38004414
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceuticals (Basel) Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceuticals (Basel) Year: 2023 Document type: Article